TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

Pavla Brachova, Samuel R. Mueting, Matthew J. Carlson, Michael J. Goodheart, Anna M. Button, Sarah L. Mott, Donghai Dai, Kristina W. Thiel, Eric J. Devor, Kimberly K. Leslie

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint Dive into the research topics of 'TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences